Daily cardiology

Impact: Management of ACS in older adults, an AHA statement 26.12.2022 6:45 ↓

Impact: ACS in the elderly

Impact: single chest x-ray could predict 10-year CVD risk 26.12.2022 4:05 ↓

Impact: one CXR to determine 10-yr CVD risk

Case Discussion No. 68 Answer: anticoagulation in pregnancy 26.12.2022 7:37 ↓

Case Discussion No. 68 Answer

PANTHER: Clopidogrel overcoming the old rival 11.12.2022 13:31 ↓

A quick review on PANTHER study

CardioWatch, Season 2 Episode 5 11.12.2022 12:48 ↓

CardioWatch S02E05

Impact: The association between dairy intake and risk of CVD in patients with stable angina pectoris 23.11.2022 4:10 ↓

Impact: Dairy consumption and cardiovascular risk

Impact: The impact of coffee subtypes on incident CVD, arrhythmias, and mortality 17.11.2022 3:53 ↓

Impact: Coffee consumption and CV risk

Impact: Experts Express Caution Over Type 2 Diabetes-Tea Drinking Claim 17.11.2022 5:33 ↓

Impact: Tea consumption and DM risk

Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after CABG 10.11.2022 8:00 ↓

Dual antiplatelet Tx. with Ticagrelor and graft failure after CABG

Impact: Improved Likelihood of Survival With the Use of the Head-Up CPR Bundle for Non-Shockable Car 03.11.2022 5:15 ↓

Impact: Improved Survival With the Head-Up CPR Bundle for Non-Shockable Cardiac Arrest

Impact: Acetaminophen in comparison to NSAIDs in cardiovascular diseases 03.11.2022 3:12 ↓

Impact: Acetaminophen vs. NSAIDs in CVD

Impact: RADIANCE II: Pivotal study, renal denervation for stage II Hypertension 03.11.2022 6:20 ↓

Impact: RADIANCE II, pivotal study

Impact: Pulmonary Artery Denervation for Pulmonary Arterial Hypertension 23.10.2022 4:27 ↓

Impact: Pulmonary Artery Denervation for PAH

Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrE 23.10.2022 5:22 ↓

Impact: Sacubitril/Valsartan and MR severity in HFrEF

Impact: Effect of statin therapy on muscle symptoms 10.10.2022 4:27 ↓

Impact: Effect of statin therapy on muscle symptoms

Case Discussion 59 Answer 26.09.2022 6:49 ↓

Case Discussion 59 Answer

Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair 26.09.2022 5:27 ↓

Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair

Case Discussion 52 Answer 26.09.2022 7:22 ↓

Case Discussion 52 Answer

Case Discussion 60 Answer 26.09.2022 9:48 ↓

Case Discussion 60 Answer

Case Discussion 57 Answer 26.09.2022 5:14 ↓

Case Discussion 57 Answer

Care Gaps in Adherence to Heart Failure Guidelines 17.09.2022 39:01 ↓

Care Gaps in Adherence to Heart Failure Guidelines

Instacath Conference 18 17.09.2022 4:51 ↓

Instacath Conference 18

Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF 16.09.2022 1:35:11 ↓

Umbrella: HF, Pharmacotherapy in HFrEF

Umbrella: Heart Failure, Panel 2, Non-pharmacologic Approach to HF Management 16.09.2022 1:39:23 ↓

Umbrella: HF, Non-pharmacologic Approach to HF

Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40% 16.09.2022 1:35:34 ↓

Umbrella: HF, Heart Failure with EF>40%